Expert opinion: Emphasis should be given to the following aspects in future studies:
Autophagy is also an important pathophysiological process in stroke. The roles of autophagy-lysosomal system in hemorrhagic stroke have been discussed in a recent review article. [14] Herein, we mainly discuss the roles and underlying mechanisms of autophagy in ischemic stroke. Autophagic flux can be triggered by ischemia stress, but its roles in ischemic stroke is still controversial. [15] Autophagy can be classified into basal and induced autophagy: Basal autophagy is a 'housekeeping' process in neurons [16] whereas induced autophagy possesses double-edged effects on neurons [17] .
Multiple autophagic protein markers such as Beclin 1
and LC3-phosphatidylethanolamine conjugate (LC3-II) were found to be robustly increased in cerebral ischemia animal models.
[18] Also, autophagososmes and autolysosomes were directly found in ischemic areas by transmission electron microscopy. [19, 20] However, the roles of autophagy in ischemic brain injury remain controversial. Series of investigations indicate that autophagy like a double-edged sword, possesses both beneficial and detrimental effects to the brain after ischemia stimulus. [ . [23, 24] Ischemia insults initiate to produce a large amount of free radicals and result in neuronal cell death, BBB disruption and neurological deficits. [25] Growing evidences suggest that ROS can mediate autophagy via posttranslational modification of biomolecules including proteins, lipids and DNA in ischemic stroke. [26, 27] However, the roles and underlying mechanisms of RNS-mediated autophagy in ischemic stroke have yet received enough attention.
In this article, we review current progress regarding the roles of autophagy in the pathological process of cerebral ischemia/reperfusion (I/R) injury. In particular, we emphasize on the roles of RNS in regulating autophagy and their potential impacts on developing novel therapeutic approaches for ischemic stroke.
Autophagy in ischemic stroke

Detection of autophagy activation in ischemic brain
Autophagy can be evaluated through the detection of multiple autophagic markers in each step or direct morphology observation of autolysosomes.
[20] Increased expression of Beclin 1 and LC3-II often serve as useful markers to indicate autophagosomes formation. Especially, labeling LC3 is commonly applied to track autophagosomes by observing its distribution change from uniform residence to punctate dots. [28] Moreover, p62/SQSTM1 has multiple domains mediating its interaction with relevant binding partners and functions as an autophagy receptor for selective degradation of ubiqutinated substrates. [29] Accompanying with the degradation of substrates, p62/SQSTM1 is also digested within autolysosomes. Thus, decreased p62/SQSTM1 level could be an indicator for autophagy maturation and degradation. [30] LC3 and p62/SQSTM1 have been documented to be specific and reliable autophagy markers in formalin fixed and paraffin embedded human tissues for immunohistochemistry. [31] With the progress of the mechanisms, we believe that more and more specific autophagy biomarkers would be discovered in future.
The activation of autophagy in ischemic stroke has been intensively studied.
Autophagic flux was not only reported in ischemic brains of experimental stroke rodent models with morphological evidences and changes of autophagic markers [32] , but also in the brains of ischemic stroke patients with increased levels of Beclin 1 and LC3 in cerebrospinal fluid and serum [33] . The appearance of autophagic vesicles has been also found in human post-mortem brain tissue after stroke.
[34] After ischemic insults, autophagic flux not only occurs in neurons [35] , but also astrocytes [36] and endothelial cells [37] . Thus, autophagy could be a critical player in the pathological process of ischemic brain injury which involves multiple cells at different stages of ischemic stroke.
Controversial roles of activated autophagy in ischemic brain injury
No consensus about the roles of activated autophagy in ischemic stroke is documented in current stage of the investigations. Yet, two things are irrefutable. One is that increased autophagy occurs in the brain in response to ischemic injury; the other is that basal level autophagy is indispensable for keeping brain function. Since these opinions are widely discussed elsewhere, we will not further elaborate here. [21, 38] It has been an intractable thematic since last decades whether the induction of autophagy benefits for cell survival or promotes cell death in cerebral ischemia injury.
Existing divergent data, like 'muddied the water', bring the complexity and challenge to evaluate the roles of activated autophagy in the pathological process of ischemic stroke. However, like pieces of the puzzle, they also provide clues to objectively understand these opposite outcomes. Growing evidences suggest that the final cell fate partly depends on the game between autophagy demand for substrate removal with cell affordability (autophagy is a adenosine triphosphate (ATP)-dependent process).
[39] Thus, it is understandable that many controversial results about the roles of autophagy have been reported in the experiments with different protocols. For better understanding those divergent results, we should consider following factors in data interpretation about the effects played by activated autophagy in ischemic stroke. Table 1 shows controversial results about the effects of autophagy on ischemic brain in literatures with different protocols. Those results appear to be confusing, but opportunity often disguises as challenge. Stark contrast studies described in the Table   1 bring a big challenge to understand the real roles of autophagy in ischemic stroke.
Potential factors responsible for divergent roles of autophagy
On the other hand, they also pave the way for finding the potential factors and developing therapeutic strategies for improving outcomes. 
Therapeutic timing of autophagy regulators
Autophagy is a dynamic regulatory process and its roles depend on different phases of ischemia. Thus, we screen and analyze relevant studies with similar experimental protocols and pay special attention on the intervening time points of autophagy regulators in both rat models [44, 45, [54] [55] [56] and mouse models [46, 47, 57] . It is obvious that administration timing of autophagy regulators could be a critical factor to different outcomes. In other words, therapeutic time points could determine the outcomes of autophagy regulation. Interestingly, the claimed beneficial effects of autophagy on ischemic brain were commonly reported in the literatures with the administration of autophagy inhibitors or activators prior to ischemic insults. [51] [52] [53] [54] [55] [56] [57] In contrast, evidences supporting the detrimental roles of autophagy in ischemic brain were often obtained from the literatures using autophagy regulators after the onset of ischemic insults or at the phase of reperfusion. [40] [41] [42] [43] [44] [45] [46] [47] Those studies indicate that autophagy activation could be an attempt for survival at early stage of cerebral ischemia, but those self-defensive functions might be pinned down by serious damages attributed by ischemia plus reperfusion. In another word, reperfusion after ischemia might be a turning point transferring autophagic roles from protective to destructive. Importance of intervening timing inspires to select proper therapeutic time point for better outcomes. 
Autophagy inhibitor or activator
Autophagy and cell death
It is self-evident that autophagy activation can play different roles in specific ischemia scenarios. Beyond this, knowledge is still limited on how autophagy alters cell fate to "blind alley". Herein, we review the progress of autophagy-induced cell death, providing insights to develop novel therapeutic strategies for ischemic stroke.
Autophagy can induce different forms of cell death under intensive stress condition like cerebral I/R injury. Merely the presence of autophagy in a dying cell does not equate to autophagic cell death.
[70] To avoid confusion, the term of 'autophagic cell death' has been redefined by the Nomenclature Committee on Cell Death (NCCD). It was described to be inhibited by genetic mutating at least two molecules of autophagy pathways.
[71] Autosis, a novel form of autophagy-dependent and non-apoptotic cell death has been identified, which is characterized by dilated and fragmented ER, ER disappearance, nuclear membrane convolution and focal swelling of the perinuclear space. [72] Furthermore, this type cell death highly depends on Na + , K + -ATPase. [73] It was revealed that autotic cell death occurred in neurons of hippocampal CA3 area in the absence of apoptosis and necrosis during cerebral hypoxia-ischemia. [73] Presumably, autosis paves the way for us to understand that autophagy has a causative link with cell death instead of only presence in dying cells.
It appears to be that unfavorable effects of autophagy on ischemic brain are partially attributed by triggering programmed cell death (PCD) to passive cell death. [74] Ischemic stroke is characterized with the interruption of cerebral blood flow to induce brain damage including cell death. Indeed, necrosis and PCD such as apoptosis have been intensively investigated under ischemic insult. [75] Necrosis predominates in the ischemic core of prompt blood flow blockage. It often occurs within several minutes triggered by abrupt ATP depletion. Morphologically, it is distinguished by the features of vacuolation in cytoplasm, plasma membrane breakdown and induction of inflammation. [76] In general, necrosis is considered as an irreversible and uncontrolled form of cell death like "a falling knife". However, the cells in the penumbra of blood flow reduction often initiate PCD in order to minimize cerebral injury. [77] PCD could be interpreted as last attempt for survival in dying cells, which at least provides therapeutic time window to intervene. [78] With the development of new techniques and high-resolution tools, new types of PCD including necroptosis [79] , pyroptosis [80] and ferroptosis [81] have been observed and identified. Next, we discuss how autophagy alters cell fate through changing the types of cell death. It is widely accepted that necrosis, apoptosis and activated autophagy often coexist in the penumbral region. Intracellular ATP level plays a determining role in switching cell death phenotypes from apoptosis to necrosis. [82] Of note, autophagy activation aggravates ATP depletion by excessive removal of damaged but still functional mitochondria and its own consumption. [83, 84] Especially, neurons are vulnerable to ATP depletion due to its high energy demand. Thus, autophagy might be a switch in the decision between apoptosis and necrosis via ATP consumption in ischemic brain.
Mitophagy in ischemic stroke
Activation of mitophagy-a selective autophagy in ischemic brain
Mitochondrial autophagy, also termed mitophagy, is identified by autophagosomes around mitochondria, recruiting LC3-II to degrade the depolarized mitochondria. [85] Besides generating more than 60% of cellular ATP via oxidative phosphorylation, mitochondria are also widely involved in regulating redox signaling and PCD Recent studies also indicate that Ambra1, Cardiolipin and SMURF1 could participate in mitophagy through serving as novel receptors to recruit the phagophores expanding to mitochondria. [90] [91] [92] Thus, mitophagy is a complex regulatory system to monitor mitochondrial quality for cell survival.
Dual roles of mitophagy in cerebral ischemia injury
Like autophagy, the roles of mitophagy in ischemic brain still remain obscure.
Mitophagy activation has been reported in different experimental conditions including middle cerebral artery occlusion (MCAO) animal models and oxygen-glucose deprived (OGD) neuronal and endothelial cell models. [53, 93] It is noteworthy that activated mitophagy is mainly evident in neurons undergoing ischemia [93, 94] , although astrocytes are also documented [95] . Mitophagy is essential to brain function via timely eliminating damaged mitochondria, which produce lots of free radicals, release cytochrome c and activate apoptosis pathway. [96, 97] In cerebral ischemia model, rapamycin attenuated cellular dysfunction via activating mitophagy, which was reversed by 3-MA. [98] However, a contrary opinion claimed that mitophagy might exacerbate brain damage under intensive ischemia stress.
[38] Like autophagy, activated mitophagy also possesses dual roles in ischemic stroke: physiological level is indispensable for cell survival and excessive level contributes to cell death. [99, 100] Mitophagy must be balanced by mitochondrial biogenesis to meet brain energy demand, or it will be fatal to the brain, at least partly induced by intracellular ATP depletion. To date, the precise roles and regulation of mitophagy in ischemic stroke still remain to be further clarified.
There is still no consensus about the roles of mitophagy in cerebral I/R injury. The major limitations of current studies could be attributed to the lack of reliable and specific methods to assess mitophagy and pharmacologic modulators to specifically regulate mitophagy. A recent study revealed that rapamycin treatment before transient Therefore, it is warranted to design series of studies using different cerebral I/R protocols and pharmacological/genomic modulation to figure out the turning points and the factors switching beneficial effects to detrimental actions of mitophagy.
Reactive nitrogen species (RNS) and autophagy
Roles of RNS during cerebral I/R injury
Undoubtedly, modulating autophagy/mitophagy in ischemic stroke will have a potential therapeutic prospect in clinical practice. Reperfusion after ischemia might be a switch to determine different autophagic/mitophagic outcomes. Thus, it is a wise choice to search and regulate key upstream signaling molecules, which majorly form or perform functions during reperfusion to mediate autophagy/mitophagy. All three NOS subtypes are expressed in the brain. NO at low concentration generated by eNOS and nNOS acts as an indispensable messenger to regulate post-or pre-synaptic activities [109] , cerebral blood flow [110] and inflammatory response [111] . Yet, excessive NO derived from iNOS and nNOS could trigger cell death and BBB leakage during I/R injury. [25] Our group has made great efforts to study the roles and mechanisms of NO in neurological deficits, neuronal cell death and BBB disruption in ischemic stroke. In our early study, by using electron paramagnetic resonance spin trapping technology and molecular biology approaches, we found that
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NO generation had two phases in ischemic brain: The first phase of NO was generated from the eNOS activation at ischemia phase but the second phase of NO generation was from the activation and upregulation of iNOS and nNOS at the stage of reperfusion. At reperfusion stage, a large amount of NO was found in both ischemic core and penumbra of the ischemic brain. Besides, non-selective NOS inhibitor 
Roles of RNS in autophagy/mitophagy
As mentioned above, reperfusion might be a decision time point to determine different outcomes of autophagy/mitophagy. Coincidentally, a large amount of RNS often trigger series of cascades after reperfusion, contributing to cerebral I/R injury.
Further evidences reveal that RNS play a role in regulating autophagy/mitophagy. [137] Thus, we summarize current investigations about the roles of RNS in autophagy/mitophagy.
NO plays its dual roles in autophagy/mitophagy, varying with different cellular context. NO, as an important cellular messenger, serves as regulatory effects via S-nitrosylated proteins (SNO-proteins). [138] Although lots of proteins possess multiple cysteine residues, only specific cysteine residues could be S-nitrosylated.
The selectivity of cysteine residues for S-nitrosylation is determined by several molecular factors and mechanisms, like proximal priority. [139] [141, 144] and AMPK [145, 146] Overall, above exciting data implicate a causal link between RNS and autophagy/mitophagy regulation. Therefore, it promises a new therapeutic opportunity in ischemic stroke via targeting RNS to modulate autophagy/mitophagy.
RNS-mediated autophagy/mitophagy under ischemia insult
Autophagy/mitophagy can be mediated by free radicals via posttranslational modification of biomolecules including proteins, lipids and DNA in ischemic stroke. [158, 159] With growing knowledge about the roles of ROS in initiating autophagy/mitophagy, emphasis has been given to the ROS-induced autophagy/mitophagy in ischemic brain injury. [36, 108] On the contrary, the importance of RNS-mediated autophagy/mitophagy in ischemic brain has yet received enough attention.
At physiological level, NO functions as a ubiquitous second messenger to modulate signal transduction pathways and maintain normal biological activities via protein S-nitrosylation modification in CNS. However, under pathological condition, aberrant SNO-proteins induced by excessive NO often lead to protein misfolding, mitochondrial fragmentation and apoptosis. [139] Current advances suggest that aberrant protein S-nitrosylation is involved in many neurodegenerative diseases. [160] For example, NO induced mitochondrial fission via S-nitrosylation of Drp1, resulting in excessive mitophagy and neuronal cell death. [161] [162] [163] In response to nitrosative stress, mitochondrial fission and the autophagosomes engulfing injured mitochondria were observed in young neurons. [163] Alternatively, under prolonged ischemic condition, NO acted as an activator to induce caveolin-1-mediated claudin-5 degradation by triggering autophagy. Moreover, NO scavenger C-PTIO and iNOS inhibitor 1400W obviously suppressed the delivery of claudin-5 for degradation. [164] Moreover, iNOS activation also participated in upregulating autophagy of vascular endothelial cells, accompanying with increased apoptosis during I/R injury. [165] Of note, nitration of tyrosine residues is a chemically distinct redox reaction from proteins tyrosine nitration were identified in I/R heart and 10 of them were from mitochondria. [167] Interestingly, mitochondrial proteins appear to be more susceptible to nitration stress. [168] Then, nitrated mitochondrial proteins like voltage-dependent anion channels [169] , electron transport chain protein subunit complexes I-V and heat shock protein-90 further trigger mitochondrial dysfunction and energy metabolism disorder. [170, 171] Besides, emerging evidence showed that ischemia stress induced tight junction proteins degradation and the underlying mechanism was at least partially contributed by ONOO --mediated autophagy. [172] Taken together, RNS-mediated autophagy/mitophagy may play an indispensable role in cerebral I/R injury. Targeting RNS and its signaling pathways could bring therapeutic benefits for ischemic stroke.
Conclusion
As elaborated above, growing evidences support that RNS-mediated excessive autophagy/mitophagy contributes to cerebral I/R injury. Indeed, autophagy/mitophagy activation in ischemic stroke has been widely accepted in last decade. RNS-mediated excessive autophagy/mitophagy could be an important mechanism in this pathological process. Thus, targeting RNS to regulate autophagy/mitophagy might be a promising combined therapeutic strategy for thrombolytic treatment to extend the therapeutic time window, improve outcomes and reduce the side effects of t-PA in stroke treatment. Therefore, further investigations on RNS-mediated autophagy/mitophagy would not only bring novel insights into the underlying mechanisms of cerebral I/R injury but also have a bright prospect to develop therapeutic strategies for ischemic stroke.
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Article highlights
1. Activated autophagy has double-edged roles in ischemic stroke. The beneficial or detrimental effects of activated autophagy on ischemic brain appear to be dependent on the experimental protocols with different intervening time points of autophagy, administration routes and doses of autophagy regulators and so forth.
2. Reperfusion after ischemia appears to act as a critical turning point determining the roles of autophagy from neuroprotection to neurotoxicity via affecting programmed cell death.
3. Mitophagy, as a selective autophagy, predominates in ischemic brain and also plays dual roles in ischemic stroke.
4. RNS-mediated excessive autophagy/mitophagy could be an important cellular event contributing to cerebral I/R injury. Targeting RNS to regulate autophagy/mitophagy might shed new light on the therapies of ischemic stroke. 
